Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine. - Wikidata - awgldk - TriplyDB

Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine.

Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine.

http://www.wikidata.org/entity/Q46906686

about

Vascular endothelial dysfunction and pharmacological treatment Hypertension: what's sex got to do with it?Renal NOS activity, expression, and localization in male and female spontaneously hypertensive rats.Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.Oleanolic acid induces relaxation and calcium-independent release of endothelium-derived nitric oxide.Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats.Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.Increased levels of asymmetric dimethylarginine and C-reactive protein are associated with impaired vascular reactivity in essential hypertension.Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases.Menthol-Induced Cutaneous Vasodilation Is Preserved in Essential Hypertensive Men and Women.Endothelium-Dependent Hyperpolarization (EDH) in Hypertension: The Role of Endothelial Ion Channels.

P2860

Q26774561-D26AF079-97F7-4C79-A932-47A5EB44C5A3 Q26866656-9327A916-6862-48A3-94E1-9E82FD3C9B44 Q33589477-2957C599-FFF3-4D5A-8FEE-5BB061829FFE Q36655988-330D20FF-25D0-4FB8-BFE8-06912CFFA018 Q36815916-B8969312-18BF-446A-B2F0-849413544464 Q36964950-B784C88E-33D6-4C36-82B0-A2015639298E Q37230725-E96078DF-7FF3-4387-87D3-A9492E4EFB08 Q37255287-AD18A925-07CD-4E25-991B-91286843B4E6 Q37324756-9497315B-0CC6-46D7-969F-1E9DDCB3B484 Q40242835-43DD8FA0-7E2B-418C-A312-C1E87AF4E80C Q43167305-05BD5B5D-3FF0-47D0-AB91-9ED3B430F81B Q45941231-0CB5A06C-016D-400C-8888-3E7E12E3B022 Q47850156-FF3CA0D0-9288-4872-92EE-79F9362AA58C Q49722369-8ED26CC5-01EC-4E60-86AD-EA2ACBA31F93

P2860

Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine.

http://www.wikidata.org/entity/Q46906686

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Reduction of NO- and EDHF-medi ...... f asymmetric dimethylarginine.

@en

Reduction of NO- and EDHF-medi ...... f asymmetric dimethylarginine.

@nl

type

label

Reduction of NO- and EDHF-medi ...... f asymmetric dimethylarginine.

@en

Reduction of NO- and EDHF-medi ...... f asymmetric dimethylarginine.

@nl

prefLabel

Reduction of NO- and EDHF-medi ...... f asymmetric dimethylarginine.

@en

Reduction of NO- and EDHF-medi ...... f asymmetric dimethylarginine.

@nl

P1433

Q46906686-FECFB02D-3E66-4B1C-AA14-B5F64D03E509

P1476

Q46906686-494C098F-AEFF-479E-86B4-787D3477F3A3

P2093

Q46906686-3C1245C8-90AD-4031-B788-A859A2ACFBDC

Q46906686-4B892850-45A6-472B-8138-4DD304547CE8

Q46906686-6F91D438-4F4B-40D2-93DC-BC74D8EB9092

Q46906686-8B54C072-A4F9-45CC-94F6-CC09DAF75B10

Q46906686-99A6AAF6-65F8-4CA4-BD43-59522909B9C7

Q46906686-A2D20AB9-08B8-44EA-99F0-07F95CECD357

Q46906686-ECBB0977-EFF0-4BE5-8830-1CDAF65CEFCE

P2860

Q46906686-03A3E1DD-E22D-47F8-A912-8FDCD24DBE0B

Q46906686-053C8C02-6FD6-4489-ADDA-247459066E4E

Q46906686-1FFD2713-2B2A-4D25-944A-2F1E8EA819FA

Q46906686-209A9003-15FA-426F-97B3-CCDD322152B3

Q46906686-2E25BB03-83C5-4ADD-8E69-A8E21E0CA619

Q46906686-32E17F33-D0E1-46D4-9497-2147B8284B34

Q46906686-44696C9A-AF6D-44B4-A549-E9342C334BE6

Q46906686-47A8686B-6E2F-4D1A-9A1B-E63AA1366946

Q46906686-4D3327C4-BED4-4D59-8AF4-63A6A455AD15

Q46906686-4E4F5BA1-BB66-42F3-9BA9-56ADB513A6F5

P304

Q46906686-BD92DE47-D641-429C-9E7D-5C248D90E53C

P31

Q46906686-7F260420-37AC-4C7E-8CB0-5FF92A9BE2F1

P356

Q46906686-130D5083-13A1-47D0-9E3B-CBCA937AA6F5

P433

Q46906686-12585542-1BD6-4FDF-AEF0-08FB893F8293

P478

Q46906686-26D4E8AE-AA79-4C8A-AAF0-A380E68C41BC

P577

Q46906686-832A5603-186F-4897-A476-E5822DB7CA55

P698

Q46906686-5F22BF15-D046-4936-B5F9-0F058E56BD3B

P921

Q46906686-89DF1666-7717-49FE-A0C3-3BD85D898A6C

P356

10641960701616194

P1433

Clinical and Experimental Hypertension

P1476

Reduction of NO- and EDHF-medi ...... f asymmetric dimethylarginine.

@en

P2093

Bin Tan

http://www.w3.org/2001/XMLSchema#string

Dai Li

http://www.w3.org/2001/XMLSchema#string

De-Jian Jiang

http://www.w3.org/2001/XMLSchema#string

Hao Liu

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Yuan-Jian Li

http://www.w3.org/2001/XMLSchema#string

Zhi Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Altered Expression of Small-Conductance Ca2+-Activated K+ (SK3) Channels Modulates Arterial Tone and Blood Pressure

Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers

Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice.

Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats.

Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation.

Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF

Pharmacological and molecular characterisation of SK3 channels in the TE671 human medulloblastoma cell line.

The role of endothelium in human hypertension.

P304

489-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10641960701616194

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17994357

http://www.w3.org/2001/XMLSchema#string

P921